Low double-digit growth in quarterly medical device sales has pushed Abbott to nudge up its earnings projections for the year. The company’s second-quarter report follows FDA green lights earlier this ...

(Reuters) -Abbott Laboratories raised its annual profit forecast on Thursday after its second-quarter earnings edged past Wall Street estimates on double-digit growth in sales of its glucose monitors ...

April 16 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab first-quarter revenue missed Wall Street estimates for medical devices on Tuesday and sales of its blockbuster psoriasis drug Stelara ...

Johnson & Johnson reported first-quarter adjusted earnings that topped expectations as sales in its medical devices business surged. The company is benefiting from a rebound in demand for nonurgent ...

On Thursday, Baxter International Inc. (NYSE:BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

(Reuters) - Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter medical devices sales fell short of Wall Street ...

Through the power of cutting-edge virtual demonstrations, sales teams are now able to reach a broader span of healthcare buyers when presenting them with the latest healthcare equipment. Instead of ...

Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Reported ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...